Published in Arch Dis Child on August 01, 2002
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Aromatase inhibitors in pediatrics. Nat Rev Endocrinol (2011) 0.95
Growth and reproductive outcomes in congenital adrenal hyperplasia. Int J Pediatr Endocrinol (2010) 0.90
Validation of automatic bone age determination in children with congenital adrenal hyperplasia. Pediatr Radiol (2013) 0.89
An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.85
Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill. Psychoneuroendocrinology (2008) 0.82
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision). Clin Pediatr Endocrinol (2015) 0.81
Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. Horm Res Paediatr (2010) 0.81
Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol (2010) 0.81
A Retrospective Analysis of the Growth Pattern in Patients with Salt-wasting 21-Hydroxylase Deficiency. Clin Pediatr Endocrinol (2014) 0.75
Clinical features of congenital adrenal insufficiency including growth patterns and significance of ACTH stimulation test. J Korean Med Sci (2013) 0.75
11-Oxygenated Androgens are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency. J Clin Endocrinol Metab (2017) 0.75
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child (1976) 12.33
Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res (2000) 4.41
Body index measurements in 1996-7 compared with 1980. Arch Dis Child (2000) 2.77
The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol (1976) 2.19
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab (1983) 1.77
Cortisol production rate in childhood and adolescence. J Pediatr (1990) 1.66
Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency. Acta Paediatr (1995) 1.49
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab (1991) 1.40
Analysis of the adolescent growth spurt using smoothing spline functions. Ann Hum Biol (1978) 1.22
Obesity in 21-hydroxylase deficient patients. Arch Dis Child (1998) 1.10
Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res (1997) 1.03
Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn (1988) 0.98
The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab (1977) 0.95
Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr (1995) 0.93
An analysis of the mid-growth and adolescent spurts of height based on acceleration. Ann Hum Biol (1985) 0.92
Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy. Acta Paediatr Jpn (1988) 0.92
17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia. Eur J Pediatr (1980) 0.89
Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens. N Z Med J (1995) 0.88
Variations in duration of pubertal growth: a mechanism compensating for differences in timing of puberty and minimizing their effects on final height. Belgian Study Group for Paediatric Endocrinology. Acta Paediatr Scand Suppl (1988) 0.88
Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth. Acta Paediatr Scand (1981) 0.87
Evaluation of young women with congenital adrenal hyperplasia: a pilot study. Horm Res (1992) 0.85
Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia. Acta Endocrinol Suppl (Copenh) (1986) 0.84
Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency. Klin Padiatr (1997) 0.82
The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol (Copenh) (1983) 0.80
Impact of sex steroids and their suppression on skeletal growth and maturation. Am J Physiol (1988) 0.80
Congenital adrenal hyperplasia. Endocrinol Metab Clin North Am (1997) 0.80
Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. Eur J Pediatr (1990) 0.79
Serum osteocalcin and insulin-like growth factor I levels in children with congenital adrenal hyperplasia. Horm Res (1999) 0.79
[Somatic puberty development in girls]. Monatsschr Kinderheilkd (1987) 0.77
Growth rate in infants with impaired renal function. J Pediatr (1988) 0.77
Plasma renin activity and the response to sodium depletion in salt-losing congenital adrenal hyperplasia. Pediatr Res (1982) 0.77
Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats. Pediatr Nephrol (1992) 0.77
Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res (2000) 4.41
Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) (1999) 3.99
The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res (1998) 3.13
Body index measurements in 1996-7 compared with 1980. Arch Dis Child (2000) 2.77
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 2.74
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
[Successful treatment and pregnancy in a women with the non-classic form of congenital adrenal hyperplasia]. Ned Tijdschr Geneeskd (2002) 2.49
Developing evidence-based guidelines for referral for short stature. Arch Dis Child (2007) 2.49
Polyamines and the accumulation of ribonucleic acid in some polyauxotrophic strains of Escherichia coli. J Bacteriol (1967) 2.32
Systemic and local regulation of the growth plate. Endocr Rev (2003) 2.14
Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study. Haemophilia (2010) 2.05
[Congenital adrenal hyperplasia: clinical aspects and neonatal screening]. Ned Tijdschr Geneeskd (2002) 2.03
[HIV prevalence among injecting drug users in South Limburg, 1994-1998/1999: increasing trend in Heerlen, not in Maastricht]. Ned Tijdschr Geneeskd (2002) 2.02
[Measuring the length of newborn infants]. Ned Tijdschr Geneeskd (2005) 1.94
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum (2012) 1.84
POLYAMINES, RNA SYNTHESIS, AND STREPTOMYCIN LETHALITY IN A RELAXED MUTANT OF E. coli STRAIN 15 TAU. Proc Natl Acad Sci U S A (1967) 1.82
Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. J Pediatr (1994) 1.73
Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience (2010) 1.70
Isolation procedure and some properties of myeloperoxidase from human leucocytes. Biochim Biophys Acta (1978) 1.67
Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem (1986) 1.67
Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev (2003) 1.66
Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum Mol Genet (1995) 1.65
On the Length of Muscle-Fibres and its Meaning in Physiology and Pathology. J Anat Physiol (1913) 1.62
3-M syndrome: description of six new patients with review of the literature. Clin Dysmorphol (2001) 1.60
Towards evidence based referral criteria for growth monitoring. Arch Dis Child (2004) 1.59
Maternal uniparental disomy 7--review and further delineation of the phenotype. Eur J Pediatr (2000) 1.56
[Potential improvements in medical education as retrospectively evaluated by candidates for specialist examinations]. Dtsch Med Wochenschr (2006) 1.55
High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2001) 1.52
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res (1998) 1.47
A 43-year-old male with untreated panhypopituitarism due to absence of the pituitary stalk: from dwarf to giant. J Clin Endocrinol Metab (2002) 1.46
Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science (1992) 1.45
Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res (2000) 1.42
Pubertal development in The Netherlands 1965-1997. Pediatr Res (2001) 1.40
The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res (1998) 1.39
Disseminated medullary thyroid carcinoma despite early thyroid surgery in the multiple endocrine neoplasia-2A syndrome. Thyroid (2005) 1.39
Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) (1995) 1.39
[Clinical characteristics and management of adolescents admitted to the emergency ward for alcohol intoxication in the region of The Hague during the period 1999-2001]. Ned Tijdschr Geneeskd (2004) 1.39
Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab (2009) 1.39
Catch-up growth. Endocr Rev (1997) 1.38
Atlantic Canada. Ergasilus labracis on Atlantic salmon. Can Vet J (1992) 1.38
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr (2000) 1.33
A method to construct age references for skewed skinfold data, using Box-Cox transformations to normality. Hum Biol (1985) 1.32
Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab (2000) 1.32
Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab (2006) 1.31
Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child (2005) 1.31
Effects of pre- and postnatal exposure to chlorinated dioxins and furans on human neonatal thyroid hormone concentrations. Environ Health Perspect (1993) 1.29
Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res (1998) 1.28
Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim Biophys Acta (1988) 1.27
The human insulin-like growth factor II gene contains two development-specific promoters. FEBS Lett (1987) 1.27
Polymer synthesis in killed bacteria: lethality of 2',3'-dideoxyadenosine. J Bacteriol (1966) 1.26
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr (2004) 1.23
Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab (2001) 1.22
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet (2008) 1.20
The human gene encoding insulin-like growth factor I is located on chromosome 12. Hum Genet (1985) 1.20
Beta-ketothiolase deficiency in a family confirmed by in vitro enzymatic assays in fibroblasts. Eur J Pediatr (1982) 1.19
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab (1999) 1.19
An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin Nutr (2001) 1.19
Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene (2008) 1.18
[Increased prevalence of overweight and obesity in Dutch children, and the detection of overweight and obesity using international criteria and new reference diagrams]. Ned Tijdschr Geneeskd (2001) 1.18
Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett (1985) 1.18
Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res (2000) 1.17
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab (1999) 1.16
Testicular adrenal rest tumours in congenital adrenal hyperplasia. Int J Pediatr Endocrinol (2009) 1.16
A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis (1979) 1.16
Treatment algorithm for postoperative upper gastrointestinal fistulas and leaks using combined vicryl plug and fibrin glue. Endoscopy (2010) 1.15
Long-term follow-up of percutaneous transhepatic therapy (PTT) in patients with definite benign anastomotic strictures after hepaticojejunostomy. Endoscopy (2001) 1.15
Methanogenic conversion of 3-s-methylmercaptopropionate to 3-mercaptopropionate. Appl Environ Microbiol (1995) 1.14
Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin. Eur J Pediatr (1985) 1.13
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II. Proc Natl Acad Sci U S A (1985) 1.13
Substrate uptake and utilization by a marine ultramicrobacterium. Microbiology (1995) 1.12
Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr (1998) 1.12
Familial X-linked mental retardation and isolated growth hormone deficiency: clinical and molecular findings. Am J Med Genet (1996) 1.11
Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr (1997) 1.10
Growth of preterm born children. Horm Res (2008) 1.10
Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child (1996) 1.09
Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med (1997) 1.09
Can GnRH-agonist treatment cause slipped capital femoral epiphysis? J Pediatr Endocrinol Metab (2001) 1.09
High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant (2009) 1.09
Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2007) 1.08
A new method for measuring antibody using radiolabeled protein A1 in a solid-phase radioimmunoassay. J Immunol Methods (1979) 1.07
Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle. J Pediatr Endocrinol Metab (2003) 1.06
High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child (2002) 1.06
Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. Hum Genet (1985) 1.05
Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis. Hum Mutat (1995) 1.05
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab (2005) 1.05
Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet (1993) 1.04